Analyze results on the foundation the trial ran on.

Inspect the raw measures behind every endpoint and assemble review-ready evidence — starting from the governed data your team already trusts.

Request Demo Back to the Platform Map

Analysis & Submission

From raw measure to review-ready evidence.

Exploration, evidence assembly, and standards exports start from the governed foundation the trial runs on — instead of another environment to load and reconcile first.

Inspectable raw measures

Deep, modality-specific views — imaging reads, ECG waveforms, spirometry efforts, questionnaires. The raw material of the analysis, inspectable by clinical science and biometrics.

Evidence assembly for review

DSMB and interim review evidence assembled from live, traceable data — no more rebuilding the same tables before every review.

SDTM & ADaM export Coming Soon

Automate export to submission standards from Vivo’s governed data model.

AI-Assisted Clinical Science

Hypotheses surfaced, evidence attached.

The clinical science agent queries the core data model and surfaces trends and hypotheses on endpoints and subpopulations — for the team to review, not to replace the analysis. Exploratory work stays clearly separated from confirmatory statistics.

Endpoint trajectories and arm-level comparisons as the data accrues
Subgroup divergences flagged for investigation
Population and deviation effects on analysis sets made visible early
Every generated hypothesis carries its query and reasoning steps

Clinical Science Agent — Generated Hypothesis

Subgroups

Divergence is sharper in the treatment arm among more-impaired subjects at baseline — suggesting a possible responder subgroup worth pre-specified follow-up.

Population

Major IP deviations concentrated in 9 subjects explain a near-empty per-protocol population — flagged months before the interim, not at it.

Safety

Injection-site reaction rate flagged for medical review — pattern consistent with SC administration route. Expectedness and causality assessment remain with the medical monitor.

Exploratory · reviewable reasoning + query attached · not a statistical conclusion · arm-level views role-gated to unblinded users

One foundation, from first patient to DSMB.

Evidence assembly for interims and DSMBs starts from the same governed foundation your team has been monitoring all along — fewer exports to reconcile, less manual preparation before each review. Your biometrics environment stays your own: Vivo hands it clean, traceable data. Where this is heading: real-time delivery of the same signals to reviewers, during the trial.